Perceptive Advisors - FOAMIX PHARMACEUTICALS LTD ownership

FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 57 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2017. The put-call ratio across all filers is 21.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of FOAMIX PHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2019$37,309,000
+9.5%
11,203,8810.0%0.74%
-19.3%
Q3 2019$34,060,000
+207.0%
11,203,881
+140.3%
0.92%
+260.0%
Q2 2019$11,095,000
-36.5%
4,661,8240.0%0.26%
-48.3%
Q1 2019$17,482,000
+10.3%
4,661,8240.0%0.49%
-18.2%
Q4 2018$15,850,000
-11.0%
4,661,824
+50.0%
0.60%
+26.7%
Q3 2018$17,806,000
+218.1%
3,107,424
+178.1%
0.48%
+223.8%
Q2 2018$5,598,000
-2.3%
1,117,3240.0%0.15%
-8.7%
Q1 2018$5,732,000
-14.6%
1,117,3240.0%0.16%
-27.8%
Q4 2017$6,715,000
-45.9%
1,117,324
-50.0%
0.22%
-5.9%
Q3 2017$12,402,000
+139.2%
2,234,648
+100.0%
0.24%
-9.2%
Q2 2017$5,184,000
-20.8%
1,117,324
-15.5%
0.26%
-30.0%
Q1 2017$6,549,000
-55.4%
1,322,9940.0%0.37%
-64.3%
Q4 2016$14,685,000
+15.5%
1,322,994
-3.7%
1.04%
+27.2%
Q3 2016$12,717,000
+151.9%
1,373,284
+72.7%
0.82%
+134.6%
Q2 2016$5,048,000795,0000.35%
Other shareholders
FOAMIX PHARMACEUTICALS LTD shareholders Q2 2017
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 4,781,708$24,530,000,0003.64%
Opaleye Management Inc. 950,000$4,873,0001.39%
DSC Advisors, L.P. 1,187,604$6,092,0001.28%
DAFNA Capital Management LLC 335,500$1,721,0000.84%
Vivo Capital, LLC 855,000$4,386,0000.62%
Stonepine Capital Management, LLC 129,756$666,0000.36%
Eversept Partners, LP 107,500$551,4750.26%
Tekla Capital Management LLC 930,398$4,773,0000.19%
Perceptive Advisors 1,117,324$5,732,0000.16%
Crestline Management, LP 217,670$1,117,0000.14%
View complete list of FOAMIX PHARMACEUTICALS LTD shareholders